Pathophysiology of acute lung injury and the acute respiratory distress syndrome

Seminars in Respiratory and Critical Care Medicine

Volumn 27, Issue 4, 2006, Pages 337-349

  Ware, Lorraine B ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acute lung injury; Acute respiratory distress syndrome; Noncardiogenic pulmonary edema; Pathophysiology

Indexed keywords

ANTICOAGULANT AGENT; ANTIOXIDANT; CYTOKINE; OXIDIZING AGENT; PROCOAGULANT; PROTEINASE; PROTEINASE INHIBITOR;

ACUTE LUNG INJURY; ADULT RESPIRATORY DISTRESS SYNDROME; ARTIFICIAL VENTILATION; BLOOD CLOTTING; CELL DAMAGE; CLINICAL FEATURE; CYTOKINE PRODUCTION; DISEASE SEVERITY; DRUG TARGETING; HUMAN; INFLAMMATION; LEUKOCYTE ACTIVATION; MOLECULAR BIOLOGY; NEUTROPHIL CHEMOTAXIS; NONCARDIOGENIC LUNG EDEMA; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; VENTILATOR;

ENDOTHELIUM, VASCULAR; HUMANS; PULMONARY EDEMA; RESPIRATORY DISTRESS SYNDROME, ADULT;

EID: 33747649790     PISSN: 10693424     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-948288     Document Type: Review

References (163)

1. Ashbaugh DG, Bigelow DB, Petty TL, et al. Acute respiratory distress in adults. Lancet 1967;2:319-323
2. Ware LB, Matthay MA. Medical progress: the acute respiratory distress syndrome. N Engl J Med 2000;342:1334-1349
3. Lewis JF, Jobe AH. Surfactant and the adult respiratory distress syndrome. Am Rev Respir Dis 1993;147:218-233
4. Gregory TJ, Longmore WJ, Moxley MA, et al. Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome. J Clin Invest 1991;88:1976-1981
5. Nuckton TJ, Alonso JA, Kallet RH, et al. Pulmonary dead-space fraction us a risk factor for death in the acute respiratory distress syndrome. N Engl J Med 2002;346:1281-1286
6. Pelosi P, D'Onofrio D, Chiumello D, et al. Pulmonary and extrapulmonary acute respiratory distress syndrome are different. Eur Respir J Suppl 2003;42:48S-56S
7. Pratt PC, Vollmer RT, Shelburne JD, et al. Pulmonary morphology in a multihospital collaborative extracorporeal membrane oxygenation project. Am J Pathol 1979;95:191-214
8. Bachofen M, Weibel ER. Alterations of the gas exchange apparatus in adult respiratory insufficiency associated with septicemia. Am Rev Respir Dis 1977;116:589-615
9. Bachofen M, Weibel ER. Structural alterations of lung parenchyma in the adult respiratory distress syndrome. Clin Chest Med 1982;3:35-56
10. Matthay MA, Zimmerman GA, Esmon C, et al. Future research directions in acute lung injury: summary of a National Heart, Lung and Blood Institute working group. Am J Respir Crit Care Med 2003;167:1027-1035
11. Anderson WR, Thielen K. Correlative study of adult respiratory distress syndrome by light, scanning, and transmission electron microscopy. Ultrastruct Pathol 1992;16:615-628
12. Matthay MA, Broaddus VC. Fluid and hemodynamic management in acute lung injury. Semin Respir Crit Care Med 1994;15:271-288
13. Ware LB, Matthay MA. Clinical practice: acute pulmonary edema. N Engl J Med 2005;353:2788-2796
14. Matthay MA, Folkesson HG, Clerici C. Lung epithelial fluid transport and the resolution of pulmonary edema. Physiol Rev 2002;82:569-600
15. Ware LH, Matthay MA. Alveolar fluid clearance is impaired in the majority of patients with acute lung injury and the acute respiratory distress syndrome. Am J Respir Crit Care Med 2001;163:1376-1383
16. Prewitt RM, McCarthy J, Wood LDH. Treatment of acute low pressure pulmonary edema in dogs. J Clin Invest 1981;67:409-418
17. Zimmerman GA, Albertine KH, Carveth HJ, et al. Endothelial activation in ARDS. Chest 1999;116:18S-24S
18. 67gallium pulmonary leak index in pulmonary edema. J Nucl Med 1996;37:1316-1322
19. Fein A, Grossman RF, Jones JG, et al. The value of edema protein measurements in patients with pulmonary edema. Am J Med 1979;67:32-39
20. Sprung C, Rackow E, Fein I, et al. The spectrum of pulmonary edema: differentiation of cardiogenic intermediate and noncardiogenic forms of pulmonary edema. Am Rev Respir Dis 1981;124:718-722
21. Matthay MA, Wiener-Kronish JP. Intact epithelial barrier function is critical for the resolution of alveolar edema in humans. Am Rev Respir Dis 1990;142:1250-1257
22. Pittet JF, MacKersic RC, Martin TR, et al. Biological markers of acute lung injury: prognostic and pathogenetic significance. Am J Respir Crit Care Med 1997;155:1187-1205
23. Fagan KA, McMurtry IF, Rodman DM. Role of endothelin-1 in lung disease. Respir Res 2001;2:90-101
24. Pittet JF, Morel DR, Hemsen A, et al. Elevated plasma endothelin-1 concentrations are associated with the severity of illness in patients with sepsis. Ann Surg 1991;213:261-264
25. Morel DR, Lacroix JS, Hemsen A, et al. Increased plasma and pulmonary lymph levels of endothelin during endotoxin shock. Eur J Pharmacol 1989;167:427-428
26. Miyauchi T, Yanagisawa M, Tomizawa T, et al. Increased concentrations of endothelin-1 and big endothelin-1 in acute myocardial infarction. Lancet 1989;2:53-54
27. Druml W, Steltzer H, Waldhausl W, et al. Endothelin-1 in adult respiratory distress syndrome. Am Rev Respir Dis 1993;148:1169-1173
28. Langleben D, Demarchie M, Laporta D, et al. Endothelin-1 in acute lung injury and the adult respiratory distress syndrome. Am Rev Respir Dis 1993;148:1646-1650
29. Sanai L, Haynes WG, Mackenzie A, et al. Endothelin production is sepsis and the adult respiratory distress syndrome. Intensive Care Med 1996;22:52-56
30. Ware LB, Conner ER, Matthay MA. von Willebrand factor antigen is an independent marker of poor outcome in patients with early acute lung injury. Crit Care Med 2001;29:2325-2331
31. Ware LB, Eisner MD, Thompson BT, et al. Significance of von Willebrand factor in septic and non-septic patients with acute lung injury. Am J Respir Crit Care Med 2004;170:766-772
32. Hurley JV. Types of pulmonary microvascular injury. Ann NY Acad Sci 1982;384:269-286
33. Wiener-Kronish JP, Albertine KH, Matthay MA. Differential responses of the endothelial and epithelial barriers of the lung in sheep to Escherichia coli endotoxin. J Clin Invest 1991;88:864-875
34. Baker CS, Evans TW, Randle BJ, et al. Damage to surfactant-specific protein in acute respiratory distress syndrome. Lancet 1999;353:1232-1237
35. Bitterman PB. Pathogenesis of fibrosis in acute lung injury. Am J Med 1992;92:39S-43S
36. Matthay MA, Eschenbacher WC, Goetzl EJ. Elevated concentrations of leukotriene D4 in pulmonary edema fluid of patients with adult respiratory distress syndrome. J Clin Immunol 1984;4:479-483
37. Parsons PE, Fowler AA, Hyers T, et al. Chemotactic activity in bronchoalveolar lavage fluid from patients with the adult respiratory distress syndrome. Am Rev Respir Dis 1985;132:490-493
38. Steinberg KP, Milberg JA, Martin TR, et al. Evolution of bronchoalveolar cell populations in the adult respiratory distress syndrome. Am J Respir Crit Care Med 1994;150:113-122
39. Warshawski FJ, Sibbald W, Driedger A, et al. Abnormal neutrophil-pulmonary interaction in the adult respiratory distress syndrome: qualitative and quantitative assessment of pulmonary-neutrophil kinetics in humans with in vivo indium-111 neutrophil scintigraphy. Am Rev Respir Dis 1986;133:792-804
40. Matthay MA. Conference summary: acute lung injury. Chest 1999;116:119S-126S
41. Prescott SM, McIntyre TM, Zimmerman G. Two of the usual suspects, platelet-activating factor and its receptor, implicated in acute lung injury. J Clin Invest 1999;104:1019-1020
42. Laufe MD, Simon RH, Flint A, et al. Adult respiratory distress syndrome in neutropenic patients. Am J Med 1986;80:1022-1026
43. Worthen GS, Downey GP. Mechanisms of neutrophil mediated injury. In: Evans TW, Haslett C, eds. ARDS Acute Respiratory Distress in Adults. London, UK: Chapman & Hall; 1996:99-114
44. Doerschuk CM, Quinlan WM, Doyle NA, et al. The role of P-selectin and ICAM-1 in acute lung injury as determined using blocking antibodies and mutant mice. J Immunol 1996;157:4609-4614
45. Folkesson HG, Matthay MA. Inhibition of CD18 or CD11b attenuates acute lung injury after acid instillation in rabbits. J Appl Physiol 1997;82:1743-1750
46. Mulligan MS, Policy MJ, Bayer RJ. Neutrophil-dependent acute lung injury: requirement for P-selectin (GMP-140). J Clin Invest 1992;90:1600-1607
47. Nagase T, Ohga E, Sudo E, et al. Intercellular adhesion molecule-1 mediates acid aspiration-induced lung injury. Am J Respir Crit Care Med 1996;154:504-510
48. Doerschuk CM. Mechanisms of leukocyte sequestration in inflamed lungs. Microcirculation 2001;8:71-88
49. Worthen GS, Schwab B, Elson EL, et al. Mechanics of stimulated neutrophils: cell stiffening induces retention in capillaries. Science 1989;245:183-185
50. Lavkan AH, Astiz ME, Rackow EC. Effects of proinflammatory cytokines and bacterial toxins on neutrophil rheologic properties. Crit Care Med 1998;26:1677-1682
51. Erzurum S, Downey G, Doherty D, et al. Mechanisms of lipopolysaccharide induced neutrophil retention. J Immunol 1992;149:154-162
52. Inano H, English D, Doerschuk C. Effect of zymosan activated plasma on deformability of rabbit polymorphonuclear leukocytes. J Appl Physiol 1992;73:1370-1376
53. Puneet P, Moochhala S, Bhatia M. Chemokines in acute respiratory distress syndrome. Am J Physiol Lung Cell Mol Physiol 2005;288:L3-15
54. Moraes TJ, Zurawska JH, Downey GP. Neutrophil granule contents in the pathogenesis of lung injury. Curr Opin Hematol 2006;13:21-27
55. Suzuki T, Moraes TJ, Vachon E, et al. Proteinase-activated receptor-1 mediates elastase-induced apoptosis of human lung epithelial cells. Am J Respir Cell Mol Biol 2005;33:231-247
56. Donnelly SC, MacGregor I, Zamani A, et al. Plasma elastase levels and the development of the adult respiratory distress syndrome. Am J Respir Crit Care Med 1995;151:1428-1433
57. Gando S, Kameue T, Nanzaki S, et al. Increased neutrophil elastase, persistent intravascular coagulation, and decreased fibrinolytic activity in patients with posttraumatic acute respiratory distress syndrome. J Trauma 1997;42:1068-1072
58. Christner P, Fein AM, Goldberg S, et al. Collagenase in the lower respiratory tract of patients with adult respiratory distress syndrome. Am Rev Respir Dis 1985;131:690-695
59. Delclaux C, d'Ortho MP, Delacourt C, et al. Gelatinases in epithelial lining fluid of patients with adult respiratory distress syndrome. Am J Physiol 1997;272:L442-L51
60. Pugin J, Verghese G, Widmer M-C, et al. The alveolar space is the site of intense inflammatory and profibrotic reactions in the early phase of ARDS. Crit Care Med 1999;27:304-312
61. Ricou B, Nicod L, Lacaraz S, et al. Matrix metalloproteinases and TIMP in acute respiratory distress syndrome. Am J Respir Crit Care Med 1996;154:346-352
62. Weiland JE, Davis B, Holter JF, et al. Lung neutrophils in the adult respiratory distress syndrome: clinical and pathophysiologic significance. Am Rev Respir Dis 1986;133:218-225
63. Lee CT, Fein AM, Lipmann M, et al. Elastolytic activity in pulmonary lavage fluid from patients with adult respiratory distress syndrome. N Engl J Med 1981;304:192-196
64. McGuire WW, Spragg RC, Cohen AB, et al. Studies on the pathogenesis of the adult respiratory distress syndrome. J Clin Invest 1982;69:543-553
65. Suter PM, Suter S, Girardin E, et al. High bronchoalveolar levels of tumor necrosis factor and its inhibitors, interleukin-1, interferon, and elastase in patients with adult respiratory distress syndrome after trauma, shock, or sepsis. Am Rev Respir Dis 1992;145:1016-1022
66. Fowler AA, Walchak S, Giclas PC, et al. Characterisation of antiprotease activity in the adult respiratory distress syndrome. Chest 1982;81:50S-51S
67. Idell S, Kucich U, Fein A, et al. Neutrophil elastase releasing factors in bronchoalveolar lavage from patients with adult respiratory distress syndrome. Am Rev Respir Dis 1985;132:1098-1105
68. Gadek JE, Pacht ER. The interdependence of lung antioxidants and antiprotease defense in ARDS. Chest 1996;110:2738-2778
69. Geerts L, Jorens PG, Willems J, et al. Natural inhibitors of neutrophil function in acute respiratory distress syndrome. Crit Care Med 2001;29:1920-1924
70. Matute-Bello G, Liles WC, Radella F II, et al. Neutrophil apoptosis in the acute respiratory distress syndrome. Am J Respir Crit Care Med 1997;156:1969-1977
71. Lesur O, Kokis A, Hermans C, et al. Interleukin-2 involvement in early acute respiratory distress syndrome: relationship with polymorphonuclear neutrophil apoptosis and patient survival. Crit Care Med 2000;28:3814-3822
72. Sookhai S, Wang JJ, McCourt M, et al. A novel therapeutic-strategy for attenuating neutrophil-mediated lung injury in vivo. Ann Surg 2002;235:285-291
73. Hussain N, Wu F, Zhu L, et al. Neutrophil apoptosis during the development and resolution of oleic acid-induced acute lung injury in the rat. Am J Respir Cell Mol Biol 1998;19:867-874
74. Goodman R, Pugin J, Lee JS, et al. Cytokine mediated inflammation in acute lung injury. Cytokine Growth Factor Rev 2003;14:523-535
75. Nathan CF. Secretory products of macrophages. J Clin Invest 1987;79:319-326
76. Miller EJ, Cohen Ali, Matthay MA. Increased interleukin-8 concentrations in the pulmonary edema fluid of patients with acute respiratory distress syndrome from sepsis. Crit Care Med 1996;24:1448-1454
77. Folkesson HG, Matthay MA, Hebert CA, et al. Acid aspiration induced lung injury in rabbits is mediated by interleukin-8 dependent mechanisms. J Clin Invest 1995;96:107-116
78. Yokoi K, Mukaida N, Harada A, et al. Prevention of endotoxemia-induced acute respiratory distress syndrome-like lung injury in rabbits by a monoclonal antibody to IL-8. Lab Invest 1997;76:375-384
79. Martin TR. Cytokines and the acute respiratory distress syndrome (ARDS): a question of balance. Nat Med 1997;3:272-273
80. Parsons PE. Interleukin-10: the ambiguity in sepsis continues. Crit Care Med 1998;26:818-819
81. Kurdowska A, Noble JM, Steinberg KP, et al. Anti-interleukin 8 autoantibody: interleukin 8 complexes in the acute respiratory distress syndrome. Am J Respir Crit Care Med 2001;163:463-468
82. Kurdowska A, Miller EJ, Noble JM, et al. Anti-IL-8 autoantibodies in alveolar fluid from patients with the adult respiratory distress syndrome. J Immunol 1996;157:2699-2706
83. Fan J, Ye RD, Malik AB. Transcriptional mechanisms in acute lung injury. Am J Physiol Lung Cell Mol Physiol 2001;281:L1037-L50
84. Christman JW, Sadikot RT, Blackwell T. The role of nuclear factor-κ B in pulmonary diseases. Chest 2000;117:1482-1487
85. Lum H, Roebuck KA. Oxidant stress and endothelial cell dysfunction. Am J Physiol Cell Physiol 2001;280:C719-C741
86. Waters CM, Savla U, Panos RJ. KGF prevents hydrogen peroxide-induced increases in airway epithelial cell permeability. Am J Physiol 1997;272:L681-L9
87. Hu P, Ischiropoulos H, Beckman JS, et al. Peroxynitrite inhibition of oxygen consumption and sodium transport in alveolar type II cells. Am J Physiol 1994;266:L628-L34
88. Haddad JJ. Oxygen homeostasis, thiol equilibrium and redox regulation of signalling transcription factors in the alveolar epithelium. Cell Signal 2002;14:799-810
89. Chabot V, Mitchell JA, Gutteridge JMC, et al. Reactive oxygen species in acute lung injury. Eur Respir J 1998;11:745-757
90. Webb HH, Tierney DF. Experimental pulmonary edema due to intermittent positive pressure ventilation with high inflation pressures: protection by positive end expiratory pressure. Am Rev Respir Dis 1974;110:556-565
91. Dreyfuss D, Basset G, Soler P, et al. Intermittent positive-pressure hyperventilation with high inflation pressures produces pulmonary microvascular injury in rats. Am Rev Respir Dis 1985;132:880-884
92. Dreyfuss D, Soler P, Basset G, et al. High inflation pressure pulmonary edema: respective effects of high airway pressure, high tidal volume, and positive end-expiratory pressure. Am Rev Respir Dis 1988;137:1159-1164
93. Bowton DL, Kong DL. High tidal volume ventilation produces increased lung water in oleic acid-injured rabbit lungs. Crit Care Med 1989;17:908-911
94. Corbridge TC, Wood LDH, Crawford GP, et al. Adverse effects of large tidal volumes and low PEEP in canine acid aspiration. Am Rev Respir Dis 1990;142:311-315
95. Tremblay L, Valenza F, Ribeiro SP, et al. Injurious ventilatory strategies increase cytokines and c-fos mRNA expression in an isolated rat lung model. J Clin Invest 1997;99:944-952
96. Pardo A, Ridge K, Segura L, et al. Gelatinase A and interstitial collagenase are upregulated during high tidal volume mechanical ventilation [abstract]. Am J Respir Crit Care Med 1996;153:A531
97. Howard AB, Alexander R, Nerem R, et al. Cyclic strain induces an oxidative stress in endothelial cells. Am J Physiol 1997;272:C421-C427
98. Slutsky AS, Tremblay LN. Multiple system organ failure: is mechanical ventilation a contributing factor? Am J Respir Crit Care Med 1998;157:1721-1725
99. The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000;342:1301-1308
100. Ranieri VM, Suter PM, Tortorella C, et al. Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome. JAMA 1999;282:54-61
101. Ware LB, Bastarache JA, Wang L. Coagulation and fibrinolysis in human acute lung injury: new therapeutic targets? Keio J Med 2005;54:142-149
102. Idell S. Anticoagulants for acute respiratory distress syndrome: can they work? Am J Respir Crit Care Med 2001;164:517-520
103. Abraham E. Coagulation abnormalities in acute lung injury and sepsis. Am J Respir Cell Mol Biol 2000;22:401-404
104. Seeger W, Hubel J, Klapettek K, et al. Procoagulant activity in bronchoalveolar lavage of severely traumatized patients-relation to development of acute respiratory distress. Thromb Res 1991;61:53-64
105. Fuchs-Buder T, deMoerloose P, Ricou B, et al. Time course of procoagulant activity and D dimer in bronchoalveolar fluid of patients at risk for or with acute respiratory distress syndrome. Am J Respir Crit Care Med 1996;153:163-167
106. Idell S, Koenig K, Fair D, et al. Serial abnormalities of fibrin turnover in evolving adult respiratory distress syndrome. Am J Physiol 1991;261:L240-L8
107. Idell S, Gonzalez K, Bradford H, et al. Procoagulant activity in bronchoalveolar lavage in the adult respiratory distress syndrome. Am Rev Respir Dis 1987;136:1466-1474
108. Idell S, James K, Levin E, et al. Local abnormalities in coagulation and fibrinolytic pathways predispose to alveolar fibrin deposition in the adult respiratory distress syndrome. J Clin Invest 1989;84:695-705
109. Ware LB, Matthay MA. Lower plasma protein C is associated with worse clinical outcomes in patients with acute lung injury [abstract]. Am J Respir Crit Care Med 2002;165:A476
110. Bertozzi P, Astedt B, Zenzius L, et al. Depressed bronchoalveolar urokinase activity in patients with adult respiratory distress syndrome. N Engl J Med 1990;322:890-897
111. Prabhakaran P, Ware LB, White KE, Cross MT, Matthay MA, Olman MA. Elevated levels of plasminogen activator inhibitor-1 in pulmonary edema fluid predict the outcome of clinical acute lung injury. Am J Physiol: Lung Cell Mol Physiol 2003;285(1):L20-L28
112. McDonald J. The yin and yang of fibrin in the airways. N Engl J Med 1990;322:929-931
113. Idell S. Extravascular coagulation and fibrin deposition in acute lung injury. New Horiz 1994;2:566-574
114. Matthay M. Severe sepsis-a new treatment with both anticoagulant and anti-inflammatory properties. N Engl J Med 2001;344:759-762
115. Vincent J-L. New therapeutic implications of anticoagulation mediator replacement in sepsis and acute respiratory distress syndrome. Crit Care Med 2000;28:S83-S5
116. Lo S, Lai L, Ja C, et al. Thrombin-induced generation of neutrophil activating factors in the blood. Am J Pathol 1988;130:22-32
117. Kaplanski G, Fabrigoule M, Boulay V, et al. Thrombin induces endothelial type II activation in vitro: IL-1 and TNF-alpha-independent IL-8 secretion and E-selectin expression. J Immunol 1997;158:5435-5441
118. Coughlin S. Thrombin signaling and protease-activated receptors. Nature 2000;407:258-264
119. Bernard G, Vincent J-L, Laterre P-F, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001;344:699-709
120. Fukuda Y, Ishizaki M, Masuda Y, et al. The role of intra-alveolar fibrosis in the process of pulmonary structural remodeling in patients with diffuse alveolar damage. Am J Pathol 1987;126:171-182
121. Martin C, Papazian L, Payan MJ, et al. Pulmonary fibrosis correlates with outcome in the adult respiratory distress syndrome. Chest 1995;107:196-200
122. Zapol WM, Trelstad RL, Coffey JW, et al. Pulmonary fibrosis in severe acute respiratory failure. Am Rev Respir Dis 1979;119:547-554
123. Pugin J, Ricou B, Stenberg KP, et al. Proinflammatory activity in bronchoalveolar lavage fluids from patients with ARDS, a prominent role for interleukin-1. Am J Respir Crit Care Med 1996;153:1850-1856
124. Chesnutt AN, Matthay MA, Tibayan FA, et al. Early detection of type III procollagen peptide in acute lung injury. Am J Respir Crit Care Med 1997;156:840-845
125. Clark JG, Milberg JA, Steinberg KP, et al. Type III procollagen peptide in the adult respiratory distress syndrome. Ann Intern Med 1995;122:17-23
126. Lindroos PM, Coin PG, Osornio-Vargas AR, et al. Interleukin-1β (IL-1β) and the IL-1β alpha 2-macroglobulin complex upregulate the platelet-derived growth factor alpha on rat pulmonary fibroblasts. Am J Respir Cell Mol Biol 1995;13:455-465
127. Martinet Y, Menard O, Vaillant P, et al. Cytokines in human lung fibrosis. Arch Toxicol Suppl 1996;18:127-139
128. Marshall R, Bellingan G, Webb S, et al. Fibroproliferation occurs early in the acute respiratory distress syndrome and impacts on outcome. Am J Respir Crit Care Med 2000;162:1783-1788
129. Olman MA, White KE, Ware L, et al. Microarray analysis indicates that pulmonary edema fluid from patients with acute lung injury mediates inflammation, mitogen gene expression, and fibroblast proliferation through bioactive interleukin-1. Chest 2002;121:69S-70S
130. Jurkovich GJ, Rivara FP, Gurney JG, et al. The effect of acute alcohol intoxication and chronic alcohol abuse on outcome from trauma. JAMA 1993;270:51-56
131. Hudson LD, Milberg JA, Anardi D, et al. Clinical risks for development of the acute respiratory distress syndrome. Am J Respir Crit Care Med 1995;151:293-301
132. Moss M, Bucher B, Moore FA, et al. The role of chronic alcohol abuse in the development of acute respiratory distress syndrome in adults. JAMA 1996;275:50-54
133. Moss M, Parsons PE, Steinberg KP, et al. Chronic alcohol abuse is associated with an increased incidence of acute respiratory distress syndrome and severity of multiple organ dysfunction in patients with septic shock. Crit Care Med 2003;31:869-877
134. Moss M, Burnham EL. Chronic alcohol abuse, acute respiratory distress syndrome, and multiple organ dysfunction. Crit Care Med 2003;31:S207-S12
135. Guidot DM, Roman J. Chronic ethanol ingestion increases susceptibility to acute lung injury: role of oxidative stress and tissue remodeling. Chest 2002;122(Suppl 6):309S-314S
136. Holguin F, Moss I, Brown LA, et al. Chronic ethanol ingestion impairs alveolar type II cell glutathione homeostasis and function and predisposes to endotoxin-mediated acute edematous lung injury in rats. J Clin Invest 1998;101:761-768
137. Velasquez A, Bechara RI, Lewis JF, et al. Glutathione replacement preserves the functional surfactant phospholipid pool size and decreases sepsis-mediated lung dysfunction in ethanol-fed rats. Alcohol Clin Exp Res 2002;26:1245-1251
138. Moss M, Guidot DM, Wong-Lambertina M, et al. The effects of chronic alcohol abuse on pulmonary glutathione homeostasis. Am J Respir Crit Care Med 2000;161:414-419
139. Bunnell E, Pacht ER. Oxidized glutathione is increased in the alveolar fluid of patients with the adult respiratory distress syndrome. Am Rev Respir Dis 1993;148:1174-1178
140. Pacht ER, Timerman AP, Lykens MG, et al. Deficiency of alveolar fluid glutathione in patients with sepsis and the adult respiratory distress syndrome. Chest 1991;100;1397-1404
141. Brown LA, Harris FL, Bechara R, et al. Effect of chronic ethanol ingestion on alveolar type II cell: glutathione and inflammatory mediator-induced apoptosis. Alcohol Clin Exp Res 2001;25:1078-1085
142. Brown LA, Harris FL, Guidot DM. Chronic ethanol ingestion potentiates TNF-alpha-mediated oxidative stress and apoptosis in rat type II cells. Am J Physiol Lung Cell Mol Physiol 2001;281:L377-L386
143. Guidot DM, Modelska K, Lois M, et al. Ethanol ingestion via glutathione depletion impairs alveolar epithelial barrier function in rats. Am J Physiol Lung Cell Mol Physiol 2000;279:L127-L135
144. Burnham E, Brown LAS, Eaton S, et al. Prolonged glutathione deficiency and increased total protein concentrations in the epithelial lining fluid of chronic alcoholics [abstract]. Am J Respir Crit Care Med 2001;163:A816
145. Baughman RP, Roselle GA. Surfactant deficiency with decreased opsonic activity in a guinea pig model of alcoholism. Alcohol Clin Exp Res 1987;11:261-264
146. Greenherg SS, Zhao X, Hua L, et al. Ethanol inhibits lung clearance of Pseudomonas aeruginosa by a neutrophil and nitric oxide-dependent mechanism, in vivo. Alcohol Clin Exp Res 1999;23:735-744
147. Omidvari K, Casey R, Nelson S, et al. Alveolar macrophage release of tumor necrosis factor-alpha in chronic alcoholics without liver disease. Alcohol Clin Exp Res 1998;22:567-572
148. Looney MR, Gropper MA, Matthay MA. Transfusion-related acute lung injury: a review. Chest 2004;126:249-258
149. Kopko PM, Marshall CS, MacKenzie MR, et al. Transfusion-related acute lung injury: report of a clinical look-back investigation. JAMA 2002;287:1968-1971
150. Silliman CC, Boshkov LK, Mehdizadehkashi Z, et al. Transfusion-related acute lung injury: epidemiology and a prospective analysis of etiologic factors. Blood 2003;101:454-462
151. Popovsky MA, Moore SB. Diagnostic and pathogenetic considerations in transfusion-related acute lung injury. Transfusion 1985;25:573-577
152. Kopko PM, Holland PV. Transfusion-related acute lung injury. Br J Haematol 1999;105:322-329
153. Silliman CC, Paterson AJ, Dickey WO, et al. The association of biologically active lipids with the development of transfusion-related acute lung injury: a retrospective study. Transfusion 1997;37:719-726
154. Zallen G, Offner PJ, Moore EE, et al. Age of transfused blood is an independent risk factor for postinjury multiple-organ failure. Am J Surg 1999;178:570-572
155. Purdy ER, Tweeddale MG, Merrick PM. Association of mortality with age of blood transfused in septic ICU patients. Can J Anaesth 1997;44:1256-1261
156. Dobbs LG, Gonzalez R, Matthay MA, et al. Highly water-permeable type 1 alveolar epithelial cells confer high water permeability between the airspace and vasculature in rat lung. Proc Natl Acad Sci USA 1998;95:2991-2996
157. Perkins GD, McAuley DF, Thickett DR, et al. The beta-agonist lung injury trial (BALTI): a randomized placebo-controlled clinical trial. Am J Respir Crit Care Med 2006;173:281-287
158. Folkesson HG, Matthay MA, Westrom BR, et al. Alveolar epithelial clearance of protein. J Appl Physiol 1996;80:1431-1445
159. Kim CF, Jackson EL, Woolfenden AE, et al. Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 2005;121:823-835
160. Ware LB, Matthay MA. Keratinocyte and hepatocyte growth factors in the lung: roles in lung development, inflammation and repair. Am J Physiol Lung Cell Mol Physiol 2002;282:L924-L40
161. Atabai K, Ishigaki M, Geiser T, Ueki I, Matthay MA, Ware LB. Keratinocyte growth factor can enhance alveolar epithelial repair by nonmitogenic mechanisms. Am J Physiol: Lung Cell Mol Physiol 2002;283:L163-L169
162. Rafii S, Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med 2003;9:702-712
163. Burnham EL, Taylor WR, Quyyumi AA, et al. Increased circulating endothelial progenitor cells are associated with survival in acute lung injury. Am J Respir Crit Care Med 2005;172:854-860